Archive: July 2023
Feature
Update on Clinical Trials for Nonalcoholic Steatohepatitis
Abstract: Tremendous effort has been put forth over the past 2 decades in understanding the pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis (NAFLD/NASH). Although multiple potential […]
Feature
New Techniques to Screen for Barrett Esophagus
Abstract: Barrett esophagus (BE) is the only known precursor to esophageal adenocarcinoma (EAC), a cancer that continues to have a poor 5-year survival rate of 20%. […]
Advances in IBD
Using a Treat-to-Target Approach to Manage Patients With Inflammatory Bowel Disease
G&H What led to the concept of a treat-to-target approach for the management of patients with inflammatory bowel disease? CS Traditional management approaches to inflammatory bowel […]
HCC in Focus
Selective Internal Radiation Therapy Using Yttrium-90 in Early and Intermediate Hepatocellular Carcinoma
G&H How does selective internal radiation therapy using yttrium-90 work? RS Selective internal radiation therapy (SIRT), also known as radioembolization, involves the intra-arterial injection of micron-sized […]
Case Study in IBD
Treatment of Genital Crohn’s Disease With Upadacitinib in a Male Child: A Case Report
The prevalence of Crohn’s disease is increasing in young children.1 However, much of the current pediatric medical treatment for refractory inflammatory bowel disease (IBD), including Crohn’s […]
Letter From the Editor
Nonalcoholic Steatohepatitis Drug Development
Worldwide, the most common cause of chronic liver disease is now nonalcoholic fatty liver disease, which affects a quarter of the population. This disease is a […]
Advances in Endoscopy
Current Status and Future Course of Disposable-Component and Single-Use Duodenoscopes
G&H What prompted the recent interest in the development of novel duodenoscope designs? NF Over the past several years, there have been many reports of outbreaks […]